Actions
  • shareshare
  • link
  • cite
  • add
add
auto_awesome_motion View all 2 versions
Publication . Other literature type . 2021

Glutamate's Role in Rapidly Acting Antidepressants

Christopher Teske;
Open Access
English
Published: 01 Jan 2021
Publisher: Unpublished
Abstract

Despite differing pharmacodynamics, ketamine and serotonergic psychedelics may share downstream effects crucial to their rapid and sustained antidepressant activity. Both ketamine and serotonergic psychedelics (SPs) have been studied as novel treatments for depression, particularly Major Depressive Disorder (MDD) and Treatment-Resistant Depression (TRD). Promising results and demonstrated benefits in preliminary research have garnered these compounds much attention. Noted for their rapidity of onset, as well as consistently observed reductions in depressive symptoms and suicidal ideation, ketamine and SPs alike offer hope where traditional antidepressants may fall short.

Download fromView all 2 sources
lock_open
Orvium
Other literature type
Providers: Orvium
moresidebar